AUPH – aurinia pharmaceuticals inc - common shares (US:NASDAQ)

News

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right [Yahoo! Finance]
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Does Aurinia's Tang-Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? [Yahoo! Finance]
Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance [Seeking Alpha]
MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com